ID

45498

Beschreibung

Principal Investigator: Shannath Merbs, MD, PhD, The Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA MeSH: Glaucoma, Open-Angle https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000461 This is a case-control study of Primary Open Angle Glaucoma (POAG). POAG is a progressive optic neuropathy that eventually leads to blindness. More than 30 million people worldwide have Primary Open Angle Glaucoma (POAG), of which greater than 3 million are blind. Gene expression changes in the retina have been observed for POAG. Several recent studies, including the GLAUGEN (*Glau*coma *G*ene *En*vironment) initiative have used GWAS to identify correlative regions of the genome. Despite this, the genetic basis of Glaucoma is not well understood. Epigenetic variation may account for low heritability and environmental effects on human disease. Despite the significant advances being made in understanding the role of epigenetics in gene regulation in other fields, little is known about the relationship between DNA methylation patterns, retinal gene expression, and retinal disease. *The goal of this study is to identify differentially methylated regions in the peripheral blood of patients with POAG.* The case identification is as per the GLAUGEN description: Cases and controls were recruited from ophthalmology clinics and were examined by ophthalmologists. For cases the clinical exam included intraocular pressure measurements, optic nerve assessment and visual field evaluation. Controls had no family history of glaucoma, normal intraocular pressure and normal optic nerves. POAG and control samples come from Massachusetts Eye and Ear Infirmary (MEEI). These samples were collected and genotyped as part of the GLAUGEN study. From the MEEI, 50 patients were selected from POAG pedigrees, to include all the probands genotyped by CIDR and are currently undergoing exome sequencing, and to include additional genotyped probands who belong to pedigrees of sufficient size and structure that parent of origin effects could be evaluated. Additional individual-level phenotype and genotype data may be obtained through the authorized access portal of phs000308 (Geneva - Glaugen GWAS Study).

Link

dbGap study = phs000461

Stichworte

  1. 03.11.22 03.11.22 - Dr. med. Lucy Kessler
  2. 13.12.22 13.12.22 - Kristina Keller
Rechteinhaber

Shannath Merbs, MD, PhD, The Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA

Hochgeladen am

13. Dezember 2022

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

dbGaP phs000461 GLAUGEN-Methylation in POAG

Eligibility Criteria

Inclusion and exclusion criteria
Beschreibung

Inclusion and exclusion criteria

Alias
UMLS CUI [1,1]
C0013893
Unrelated individuals were selected as cases or controls for this study. All subjects consented to sharing their samples. Both cases and controls were examined by a trained ophthalmologist. All cases and controls were at least 35 years old and all were Caucasian. Cases had either reproducible visual field loss in at least one eye in a nerve fiber layer distribution on two independent reliable visual fields, or a vertical cup to disc ratio (CDR) of at least 0.8 in the one eye. For automated visual fields, a reliable visual field was defined by fixation loss ≤ 33%, false positive rate ≤ 20% and false negative rate ≤ 20%. Intraocular pressure was noted for all cases, but was not part of the case definition. Exclusion criteria for cases included: myopia of −8D or greater, clinical findings suggestive of secondary glaucomas (pigment dispersion, exfoliation and anterior segment dysgenesis) and narrow filtration angles. Controls did not have a family history of glaucoma, had intraocular pressures less than 21 mmHg, had vertical cup to disc ratios of less than 0.7 and CDR asymmetry of less than 0.2. Controls also did not have any evidence of secondary glaucomas or narrow filtration angles.
Beschreibung

Elig.phs000461.v1.p1.1

Datentyp

boolean

Alias
UMLS CUI [2,1]
C3846158

Ähnliche Modelle

Eligibility Criteria

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Inclusion and exclusion criteria
C0013893 (UMLS CUI [1,1])
Elig.phs000461.v1.p1.1
Item
Unrelated individuals were selected as cases or controls for this study. All subjects consented to sharing their samples. Both cases and controls were examined by a trained ophthalmologist. All cases and controls were at least 35 years old and all were Caucasian. Cases had either reproducible visual field loss in at least one eye in a nerve fiber layer distribution on two independent reliable visual fields, or a vertical cup to disc ratio (CDR) of at least 0.8 in the one eye. For automated visual fields, a reliable visual field was defined by fixation loss ≤ 33%, false positive rate ≤ 20% and false negative rate ≤ 20%. Intraocular pressure was noted for all cases, but was not part of the case definition. Exclusion criteria for cases included: myopia of −8D or greater, clinical findings suggestive of secondary glaucomas (pigment dispersion, exfoliation and anterior segment dysgenesis) and narrow filtration angles. Controls did not have a family history of glaucoma, had intraocular pressures less than 21 mmHg, had vertical cup to disc ratios of less than 0.7 and CDR asymmetry of less than 0.2. Controls also did not have any evidence of secondary glaucomas or narrow filtration angles.
boolean
C3846158 (UMLS CUI [2,1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video